Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation

Journal of Experimental Medicine

Volumn 179, Issue 5, 1994, Pages 1695-1699

  Cassatella, Marco A ^a,c   Meda, Lucia ^b   Gasperini, Sara ^a   Calzetti, Federica ^a   Bonora, Stefano ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Istituto di Patologia Generale   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESSENGER RNA; TUMOR NECROSIS FACTOR;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STIMULATION; DRUG EFFECT; GENE EXPRESSION; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL; RNA ANALYSIS; RNA DEGRADATION;

EID: 0028287092     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.179.5.1695     Document Type: Article

References (30)

1. Gallin, J.I., I.M. Goldstein, and R. Snyderman. 1992. Inflammation: Basic Principles and Clinical Correlates. 2nd edition. Raven Press Ltd., New York. 1186 pp.
2. Loyd, A.R., and J.J. Oppenheim. 1992. Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. Immunol. Today. 13:169.
3. Tiku, K., M.L. Tiku, S. Liu, and J.L. Skosey. 1986. Normal human neutrophil are a source of a specific interleukin 1 inhibitor. J. Immunol. 136:3686.
4. Ulich, T.R., K. Guo, S. Yin, J. del Castillo, E.S. Yi, R.C. Thompson, and S.P. Eisenberg. 1992. Endotoxin-induced cytokine gene expression in vivo. IV. Expression of interleukin 1-α/β and interleukin 1 receptor antagonist mRNA during endotoxemia and during endotoxin-initiated local acute inflammation. Am. J. Pathol. 141:61.
5. McColl, S.R., R. Paquin, C. Ménard, and A.D. Beaulieu. 1992. Human neutrophils produce high levels of the interleukin 1 receptor antagonist in response to granulocyte/macrophage colony-stimulating factor and tumor necrosis factor. J. Exp. Med. 176:593.
6. Arend, W.P., F.G. Goslin, and R.J. Massoni. 1985. Effects of immune complexes on production by human monocytes of interleukin 1 or an interleukin 1 inhibitor. J. Immunol. 134:3868.
7. Seckinger, P.J., W. Lowenthal, K. Williamson, J.M. Dayer, and H.R. MacDonald, 1987. A urine inhibitor of interleukin 1 activity that blocks ligand binding. J. Immunol. 139:1546.
8. Eisenberg, S.P., R.J. Evans, W.P. Arend, E. Verderber, M.T. Brewer, C.H. Hannum, and R.C. Thompson. 1990. Primary structure and functional expression from complementary DNA of a human interleukin 1 receptor antagonist. Nature (Lond.). 343:341.
9. Carter, D.B., M.R. Deibel, Jr., C.J. Dunn, C.S. Tomich, A.L. Laborde, J.L. Slightom, A.E. Berger, M.J. Bienkowski, F.F. Sun, R.N. McEwan, et al. 1990. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein. Nature (Lond.). 344:633.
10. Dripps, D.J., B.J. Brandhuber, R.C. Thompson, and S.P. Eisenberg. 1991. Interleukin 1 (IL-1) receptor antagonist binds to the 80-kDa IL-1 receptor but does not initiate signal transduction. J. Biol. Chem. 266:10331.
11. Ohlsson, K., P. Bjork, M. Bergenfeldt, R. Hageman, and R.C. Thompson. 1990. An interleukin 1 receptor antagonist reduces mortality in endotoxin shock. Nature (Lond.). 348:550.
12. Cominelli, F., C.C. Nast, B.D. Clark, R. Schindler, R. Lierena, V.E. Eysselein, R.C. Thompson, and C.A. Dinarello. 1990. Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis. J. Clin. Invest. 86:972.
13. Moore, K.W., A. O'Garra, R. de Waal Malefyt, P. Vieira, and TR. Mosmann. 1993. Interleukin 10. Annu. Rev. Immunol. 11:165.
14. Cassatella, M.A., L. Meda, S. Bonora, M. Ceska, and G. Constatin. 1993. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1β in mediating the production of IL-8 triggered by lipopolysaccharide. J. Exp. Med. 178:2207.
15. Cassatella, M.A., F. Bazzoni, R.M. Flynn, S. Dusi, G. Trinchieri, and F. Rossi. 1990. Molecular basis of Interferon-γ and lypopolysaccharide enhancement of phagocyte respiratory burst capability. Studies on the gene expression of several NADPH oxidase components. J. Biol. Chem. 265:20241.
16. Malech, H.L. 1993. Phagocyte oxidative mechanisms. Curr. Opin. Hematol. 1:123.
17. Dinarello, C.A., and S.M. Wolff. 1993. The role of Interleukin-1 in disease. N. Engl. J. Med. 328:106.
18. Kern, J.A., R.J. Lamb, J.C. Reed, R.P. Daniele, and P.C. Nowell. 1988. Dexamethasone inhibition of Interleukin 1 Beta production by human monocytes. Posttranscriptional mechanisms. J. Clin. Invest. 81:237.
19. Novic, D., H. Engelmann, D. Wallach, and M. Rubinstein. 1989. Soluble cytokine receptors are present in normal human urine. J. Exp. Med. 170:1409.
20. Colotta, F., F. Re, M. Muzio, R. Bertini, N. Polentarutti, M. Sironi, J.G. Giri, S.K. Dower, J.E. Sims, and A. Mantovani. 1993. Interleukin-1 type II receptor: a decoy target for iL-1 that is regulated by IL-4. Science (Wash. DC). 261:472.
21. Re, F., M. Mengozzi, M. Muzio, C. Dinarello, A. Mantovani, and F. Colotta. 1992. Expression of interleukin 1 receptor antagonist by human circulating polymorphonuclear cells. Eur. J. Immunol. 23:570.
22. de Waal Malefyt, R., J. Abrams, B. Bennett, G.G. Figdor, and J.E. de Vries. 1991. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J. Exp. Med. 174:1209.
23. Fiorentino, D.F., A. Zlotnik, T.R. Mosmann, M. Howard, and A. O'Garra. 1991. Interleukin 10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815.
24. Bogdan, C., Y. Vodovotz, and C. Nathan. 1991. Macrophage deactivation by interleukin 10. J. Exp. Med. 174:1549.
25. Bogdan, C., J. Paik, Y. Vodovotz, and C. Nathan. 1992. Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J. Biol. Chem. 267:23301.
26. Caput, D., B. Keutler, K. Hartog, R. Thayer, S. Brown-Shimer, and A. Cerami. 1986. Identification of a common nucleotide-sequence in the 3′-untranslated region of mRNA molecule specifying inflammatory mediators. Proc. Natl. Acad. Sci. USA. 83:1670.
27. Gérard, C., C. Bruyns, A. Marchant, D. Abramowicz, P. Vandenabeele, A. Delvaux, W. Fiers, M. Goldman, and T. Velu. 1993. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J. Exp. Med. 177:547.
28. Howard, M., T. Muchamuel, S. Andrade, and S. Menon. 1993. Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 177:1205.
29. Kuhn, R., J. Lohler, D. Rennick, K. Rajewsky, and W. Muller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 75:263.
30. Podolsky, D.K. 1991. Inflammatory bowel disease. N. Engl. J. Med. 325:928.